MARKET OVERVIEW
Quantum computing promises to revolutionize drug discovery by enabling molecular simulations impossible on classical computers. McKinsey projects quantum applications in pharma could generate $200-500 billion in value by 2035, with near-term utility expected between 2028-2035 as error-corrected quantum systems mature.
PHARMA PARTNERSHIPS
- IBM Quantum Network: Merck, Biogen, Boehringer Ingelheim partnerships
- Google Quantum AI: Collaboration with Boehringer for molecular simulation
- IonQ: Partnerships with Dow, Hyundai for molecular modeling
- D-Wave: Optimization problems in clinical trial design
KEY APPLICATIONS
- Protein Folding: Quantum simulation of protein conformations
- Molecular Dynamics: Electronic structure calculations for drug-target interactions
- Virtual Screening: Quantum-enhanced library screening
- ADME Prediction: More accurate pharmacokinetic modeling
TIMELINE TO UTILITY
- 2024-2027: NISQ era - hybrid quantum-classical algorithms
- 2028-2030: Early fault-tolerant systems for small molecules
- 2030-2035: Full utility for complex biological simulations